Cutler Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CIP
EC
BCM
BG
Cutler Group's TNDM Position: Q1 2023 in Review
Cutler Group sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 171 shares — an estimated $7K sold.
Cutler Group first reported a position in TNDM in Q4 2015 and held it in 17 quarters. The position peaked at $168K in Q1 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.
- Cutler Group reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
- Cutler Group sold 171 Tandem Diabetes Care shares in Q1 2023, an estimated $7K.
- Cutler Group first reported a position in Tandem Diabetes Care in Q4 2015 and held it in 17 quarters.
- Cutler Group's Tandem Diabetes Care position peaked at $168K in Q1 2022.
- 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.
Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.